Cargo, biogenesis and functions of extracellular vesicles released during HSV-1 infection

HSV-1感染期间释放的细胞外囊泡的货物、生物发生和功能

基本信息

  • 批准号:
    10652535
  • 负责人:
  • 金额:
    $ 48.66万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-07-01 至 2026-06-30
  • 项目状态:
    未结题

项目摘要

Following productive, lytic infection in mucosal epithelial cells located at the portal of entry in the body, herpes simplex virus-1 (HSV-1) establishes a lifelong, silent infection in sensory neurons. The virus is occasionally reactivated due to weakened immune response or stress causing diseases that range in severity from benign cold sores to encephalitis. HSV-1 contributes to exacerbation of neurodegenerative diseases such as Alzheimer's and facilitates infection by other pathogens such as HIV-1. Extracellular vesicles (EVs) are released by all types of cells, as they constitute a major mechanism of intercellular communication, and they can influence recipient cell functions. During HSV-1 infection two populations of EVs are readily detectable. The first population is produced through a tetraspanins biogenesis pathway. These are the most abundant EVs released from HSV-1 infected cells, which are enriched in CD63 tetraspanin and carry host factors such as the STimulator of INterferon Genes (STING), a sensor of DNA in the cytosol. These CD63+ EVs can activate innate immune responses in uninfected recipient cells and suppress a subsequent HSV-1 infection. The second population of EVs is produced through the endosomal sorting complex required for the transport (ESCRT) pathway, thus we named them ESCRT+ EVs. These EVs carry ESCRT components along with selected viral tegument and envelope protein and they appear to have a proviral role. In addition to these two population of EVs, earlier studies have reported the production of capsidless particles during HSV-1 infection composed of tegument and envelope proteins but lacking viral genome. These particles are lighter than HSV-1 virions and are known as L-particles. L-particles resemble the ESCRT+ EVs in that they carry viral proteins and have a proviral effect but are denser than ESCRT+ EVs and enriched in viral proteins. We hypothesize that distinct populations of EVs are released during HSV- 1 infection with different effects on the infection. To test our hypothesis, we have formulated three Aims. In Aim 1, we propose to compare the cargo of ESCRT+ EVs and CD63+ EVs with L-particles produced during HSV-1 infection using a mass spectrometry approach. The results of this analysis will generate important information about messages communicated by infected cells. In Aim 2, we propose to determine EV biogenesis pathways involved in the production of ESCRT+ EVs, CD63+ EVs and L-particles during HSV-1 infection. For this, we will use a gene silencing approach to compromise selected EV biogenesis pathways or we will use mutant viruses to determine the impact of selected viral genes on EV biogenesis. In Aim 3, we propose to determine the type of responses that CD63+ EVs, ESCRT+ EVs and L-particles trigger in recipient cells and determine the consequences to the infection. These studies will provide important information on the biogenesis, cargo, and functions of EVs released by HSV-1 infected cells, which are essential to determine their impact on HSV-1 pathogenesis.
单纯疱疹病毒-1(HSV-1)在位于人体入口处的粘膜上皮细胞中产生裂解感染后,在感觉神经元中建立了终生的、沉默的感染。由于免疫反应减弱或压力导致的疾病,从良性唇疱疹到脑炎,病毒偶尔会被重新激活。单纯疱疹病毒1型有助于阿尔茨海默氏症等神经退行性疾病的恶化,并促进艾滋病毒-1等其他病原体的感染。细胞外小泡(EV)由所有类型的细胞释放,因为它们构成了细胞间通讯的主要机制,并且它们可以影响受体细胞的功能。在HSV-1感染期间,很容易检测到两种EV群体。第一个种群是通过Tetraspanins生物发生途径产生的。这些是HSV-1感染细胞释放的最丰富的EV,富含CD63 Tetraspan,并携带宿主因子,如干扰素基因刺激物(STING),胞浆中DNA的传感器。这些CD63+EV可以激活未感染的受体细胞的先天免疫反应,并抑制随后的HSV-1感染。第二类EVS是通过转运途径所需的内体分选复合体(ESCRT)产生的,因此我们将其命名为ESCRT+EVS。这些EV携带ESCRT组件以及选定的病毒被膜和包膜蛋白,它们似乎具有前病毒作用。除了这两种EV外,早期的研究已经报道了在HSV-1感染过程中产生无衣壳颗粒,由被膜和包膜蛋白组成,但缺乏病毒基因组。这些粒子比单纯疱疹病毒1型病毒粒子轻,被称为L粒子。L颗粒与ESCRT+EVS相似,因为它们携带病毒蛋白并具有前病毒效应,但比ESCRT+EVS密度更大,并富含病毒蛋白。我们假设,在HSV-1感染期间,不同的EV群体被释放,对感染产生不同的影响。为了检验我们的假设,我们制定了三个目标。在目标1中,我们建议用质谱学方法比较ESCRT+EVS和CD63+EVS货物与单纯疱疹病毒1型感染过程中产生的L颗粒的差异。这一分析的结果将产生有关受感染细胞传递的信息的重要信息。在目的2中,我们提出了在HSV-1感染过程中EV的生物发生途径,该途径参与了ESCRT+EV、CD63+EV和L颗粒的产生。为此,我们将使用基因沉默的方法来影响选定的EV生物发生途径,或者我们将使用突变病毒来确定选定的病毒基因对EV生物发生的影响。在目标3中,我们建议确定CD63+EVS、ESCRT+EVS和L-颗粒在受体细胞中触发的反应类型,并确定感染的后果。这些研究将提供关于HSV-1感染细胞释放的EV的生物发生、货物和功能的重要信息,这些信息对于确定它们对HSV-1致病机制的影响是必不可少的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Maria Kalamvoki其他文献

Maria Kalamvoki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Maria Kalamvoki', 18)}}的其他基金

Cargo, biogenesis and functions of extracellular vesicles released during HSV-1 infection
HSV-1感染期间释放的细胞外囊泡的货物、生物发生和功能
  • 批准号:
    10439839
  • 财政年份:
    2021
  • 资助金额:
    $ 48.66万
  • 项目类别:
Cargo, biogenesis and functions of extracellular vesicles released during HSV-1 infection
HSV-1感染期间释放的细胞外囊泡的货物、生物发生和功能
  • 批准号:
    10273664
  • 财政年份:
    2021
  • 资助金额:
    $ 48.66万
  • 项目类别:
Immunomodulatory effects of coronavirus membrane proteins E, M, and S.
冠状病毒膜蛋白 E、M 和 S 的免疫调节作用。
  • 批准号:
    10178404
  • 财政年份:
    2020
  • 资助金额:
    $ 48.66万
  • 项目类别:
Alterations in the surfaceome of the herpes simplex virus 1 infected cells via the Cbl/CIN85 endocytic machinery and the role of the Infected Cell Protein No 0 (ICP0) in endocytosis.
通过 Cbl/CIN85 内吞机制改变单纯疱疹病毒 1 感染细胞的表面组,以及感染细胞 0 号蛋白 (ICP0) 在内吞作用中的作用。
  • 批准号:
    9893313
  • 财政年份:
    2020
  • 资助金额:
    $ 48.66万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了